Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans

Clinical and Experimental Immunology

Volumn 152, Issue 1, 2008, Pages 147-152

  Taudorf, S ^a,b   Krabbe, K S ^a   Berg, R M G ^a   Moller K ^a   Pedersen, B K ^a   Bruunsgaard, H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Cytokine; Human endotoxaemia; Low grade inflammation; Single nucleotide polymorphism

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EXPOSURE; ESCHERICHIA COLI; FEMALE; GENE TARGETING; GENOTYPE; GROUPS BY AGE; HERITABILITY; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VOLUNTEER;

ADULT; CYTOKINES; ENDOTOXEMIA; ENDOTOXINS; HUMANS; INTERFERON TYPE II; INTERLEUKINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40449097594     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03612.x     Document Type: Article

References (28)

1. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992 267 : 23301 8.
2. McDonald PP, Fadok VA, Bratton D, Henson PM. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-{beta} in macrophages that have ingested apoptotic cells. J Immunol 1999 163 : 6164 72.
3. de Maat MPM, Bladbjerg EM, Bornemann Hjelmborg J, Bathum L, Jespersen J, Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 2004 24 : 2168 73.
4. de Craen AJM, Posthuma D, Remarque EJ, van den Biggelaar AHJ, Westendorp R, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005 6 : 167 70.
5. Bruunsgaard H, Christiansen L, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. The IL-6-174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans. Exp Gerontol 2004 39 : 255 61.
6. Bruunsgaard H, Benfield TL, Andersen-Ranberg K et al. The tumor necrosis factor alpha -308G>A polymorphism is associated with dementia in the oldest old. J Am Geriatr Soc 2004 52 : 1361 6.
7. Kubaszek A, Pihlajamaki J, Komarovski V et al. Promoter polymorphisms of the TNF-{alpha} (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 2003 52 : 1872 6.
8. Scassellati C, Zanardini R, Squitti R et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 2004 356 : 119 22.
9. Krabbe KS, Mortensen EL, Avlund K et al. Genetic priming of a proinflammatory profile predicts low IQ in octogenarians. Neurobiol Aging 2007 (in press).
10. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998 102 : 1369 76.
11. Heesen M, Bloemeke BP, Heussen NM, Kunz DM. Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines. Crit Care Med 2002 30 : 664 9.
12. Qi L, van Dam RM, Meigs JB, Manson JE, Hunter D, Hu FB. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 2006 15 : 1914 20.
13. Fijen JW, Tulleken JE, Hepkema BG, van der Werf TS, Ligtenberg JJM, Zijlstra JG. The influence of tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphism on the inflammatory response in experimental human endotoxemia. Clin Infect Dis 2001 33 : 1601 3.
14. Elin RJ, Wolff SM, McAdam KP et al. Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis 1981 144 : 329 36.
15. Taudorf S, Krabbe KS, Berg RMG, Pedersen BK, Møller K. Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Clin Vaccine Immunol 2007 14 : 250 5.
16. Lio D, Annoni G, Licastro F et al. Tumor necrosis factor-alpha-308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev 2006 127 : 567 71.
17. Bruunsgaard H, Pedersen AN, Schroll M, Skinhøj P, Pedersen BK. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol 1999 118 : 235 41.
18. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O'Keefe GE. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 2003 20 : 218 23.
19. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997 94 : 3195 9.
20. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002 162 : 1028 32.
21. Tulic MK, Hurrelbrink RJ, Prele CM et al. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 2007 179 : 132 40.
22. Etokebe GE, Bulat-Kardum L, Johansen MS et al. Interferon-gamma gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis. Scand J Immunol 2006 63 : 136 41.
23. Sallakci N, Coskun M, Berber Z et al. Interferon-[gamma] gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response. Tuberculosis 2007 87 : 225 30.
24. Koivisto A, Helisalmi S, Pihlajamaki J et al. Interleukin-6 promotor polymorphism and late onset Alzheimer's disease in the Finnish population. J Neurogenet 2005 19 : 155 61.
25. Chiappelli M, Tampieri C, Tumini E et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005 32 : 349 53.
26. Sookoian SC, Gonzalez C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor {alpha} gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005 13 : 2122 31.
27. Kiszel P, Mako V, Prohaszka Z, Cervenak L. Interleukin-6-174 promoter polymorphism does not influence IL-6 production after LPS and IL-1beta stimulation in human umbilical cord vein endothelial cells. Cytokine 2007 40 : 17 22.
28. Endler G, Marsik C, Joukhadar C et al. The interleukin-6 G(-174) C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 2004 50 : 195 200.